Title |
Herpetic esophagitis following bendamustine-containing regimen
|
---|---|
Published in |
Therapeutics and Clinical Risk Management, June 2016
|
DOI | 10.2147/tcrm.s98217 |
Pubmed ID | |
Authors |
Hiromichi Yamane, Yasumasa Monobe, Tomohiro Tanikawa, Nobuaki Ochi, Yoshihiro Honda, Hirofumi Kawamoto, Nagio Takigawa |
Abstract |
A 76-year-old Japanese woman presented to our hospital with anorexia. Two years before, she was diagnosed with non-Hodgkin's lymphoma and had received ten cycles of systemic chemotherapy. After salvage chemotherapy with bendamustine and rituximab (B-R), bone marrow suppression had lasted >3 months. Esophagogastroscopy revealed polynesic white protrusions in the mid-esophagus. These lesions were diagnosed as herpetic esophagitis. To the best of our knowledge, there is no other report in which herpetic esophagitis has been documented as an adverse event of B-R regimen. Because the complication could cause symptomatic gastrointestinal discomfort, physicians should be aware of this disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 23% |
Other | 2 | 15% |
Student > Bachelor | 2 | 15% |
Student > Doctoral Student | 2 | 15% |
Professor | 1 | 8% |
Other | 1 | 8% |
Unknown | 2 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 38% |
Arts and Humanities | 1 | 8% |
Agricultural and Biological Sciences | 1 | 8% |
Nursing and Health Professions | 1 | 8% |
Unknown | 5 | 38% |